Patent · US Active

Compositions and methods for inhibiting expression of klf-1 and bcl11a genes

US9127275B2 · kind B2 · utility

0Cited by
0References
44Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2011
Grant dateSep 8, 2015
Priority date
Expiry dateDec 9, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/344
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the KLF1 gene and the BCL11A gene, and methods of using such dsRNA compositions to inhibit expression of KLF1 and BCL11 A, respectively.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.